Jon Cuthbert

Fleetwood (ASX:FWD) has appointed Andrea Pidcock as its new CEO, effective Feb. 2.

Diversified United Investment (ASX:DUI) has entered into a formal implementation deed to merge with Australian United Investment (ASX:AUI).

Sandisk (NASDAQ:SNDK) reported second-quarter revenue that exceeded its own forecasts, bolstered by a surge in demand for artificial intelligence infrastructure.

A.O. Smith (NYSE:AOS) delivered record earnings for fiscal 2025, overcoming stagnant sales volumes through improved pricing and operational efficiency.

Trane Technologies (NYSE:TT) reported a robust end to 2025, fueled by an unprecedented surge in demand for high-efficiency climate solutions.

MarineMax (NYSE:HZO), the world’s largest recreational boat and yacht retailer, reported a complex start to fiscal 2026, as robust consumer demand for the boating lifestyle was offset by a stubbornly competitive promotional environment.

Altria Group (NYSE:MO) reported a resilient finish to 2025, navigating a structural decline in the combustible cigarette market with aggressive pricing and a rapidly expanding smoke-free portfolio.

OSL Group has raised $200 million in equity financing as it accelerates global expansion of its stablecoin trading and digital payments operations.

Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, reported financial results for the fourth quarter and full year ended December 31, 2025.

Alvotech (NASDAQ:ALVO) has resolved all remaining patent litigation surrounding its biosimilar candidate for the blockbuster eye drug Eylea (aflibercept), reaching a comprehensive global licensing agreement with Regeneron Pharmaceuticals and Bayer AG.